Mutations identified in the Growth Differentiation Factor 2 (GDF2) gene, which codes for the BMP9 ligand, have been observed in PAH patients, associated with reduced levels of BMP9 and BMP10 in the blood. This evidence concerns the gene GDF2 and pulmonary arterial hypertension.